Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction

Clinical Journal of Pain

Volumn 14, Issue 2, 1998, Pages 97-106

  Hautkappe, Martin ^a   Roizen, Michael F ^a   Toledano, Alicia ^a   Roth, Steven ^a   Jeffries, Jane A ^a   Ostermeier, Andreas M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amputation stump pain; Capsaicin, topical; Headache, cluster; Loin pain hematuria syndrome; Mucositis; Neural dysfunction; Neuralgia; Postmastectomy pain syndrome; Pruritus; Psoriasis Reflex sympathetic dystrophy; Rhinopathy; Substance P

Indexed keywords

CAPSAICIN;

AMPUTATION STUMP; ANALGESIA; CLUSTER HEADACHE; HUMAN; LOW BACK PAIN; MASTECTOMY; MUCOSA INFLAMMATION; NEURALGIA; NOSE DISEASE; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REVIEW; SYMPATHETIC DYSTROPHY; TOPICAL DRUG ADMINISTRATION;

CAPSAICIN; HUMANS; NERVOUS SYSTEM DISEASES; PAIN; SKIN DISEASES;

EID: 0031837105     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-199806000-00003     Document Type: Review

References (83)

1. Bernstein JE. Capsaicin and substance P. Clin Dermatol 1992;9:497-503.
2. Surh Y-J, Lee SS. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci 1995;56:1845-55.
3. Dray A. Mechanism of action of capsaicin-like molecules on sensory neurons. Life Sci 1992;51:1759-65.
4. Maggi CA. Therapeutic potential of capsaicin-like molecules: studies in animals and humans. Life Sci 1992;51:1777-81.
5. Gamse R, Petsche U, Lembeck F, et al. Capsaicin applied to peripheral nerve inhibits axoplasmic transport of substance P and somatostatin. Brain Res 1982;239:447-62.
6. Jancso G, Kiraly E, Jancso-Gabor A. Direct evidence for an axonal site of action of Capsaicin. Naunyn Schmiedebergs Arch Pharmacol 1980;313:91-4.
7. Harmar A, Schofield JG, Keen P: Cycloheximide-sensitive synthesis of substance P by isolated dorsal root ganglia. Nature 1980;284:267-9.
8. Roberts RG, Westerman RA, Widdop RE, et al. Effects of capsaicin on cutaneous vasodilator responses in humans. Agents Actions 1992;37:53-9.
9. Craft RM, Porreca F. Treatment parameters of desensitization to capsaicin. Life Sci 1992;51:1767-75.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
11. Berberian B, Bernstein JE, Dodd WA, et al. Double-blind evaluation of capsaicin cream in pruritic psoriasis [abstract]. Clin Res 1990;38: 664A.
12. Lotti T, Teofoli P, Tsampu D. Treatment of aquagenic pruritus with topical capsaicin cream. J Am Acad Dermatol 1994;30:232-5.
13. Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995;32:287-9.
14. Knight TE, Hayashi T. Solar (brachioradial) pruritus - response to capsaicin cream. Int J Dermatol 1994;33:206-9.
15. Leibsohn E. Treatment of notalgia paresthetica with capsaicin. Cutis 1992;49:335-6.
16. Wallengren J. Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 1991;24:286-8.
17. Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993; 29:438-42.
18. Rumsfield JA, West DP. Topical capsaicin in dermatologic and peripheral pain disorders. DICP 1991;25:381-7.
19. Breneman DL, Cardone JS, Blumsack RF, et al. Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 1992;26:91-4.
20. Goodless DR, Eaglstein WH. Brachioradial pruritus: treatment with topical capsaicin. J Am Acad Dermatol 1993;29:783-4.
21. Szeimies R-M, Stolz W, Wlotzke U, et al. Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 1994;131:380-2.
22. Wlotzke U, Stolz W, Hohenleutner U, et al. Interdisziplinare aspekte der notalgia paraesthetica. Dtsch Med Wochenschr 1994;119: 1307-11.
23. Farber EM, Nickoloff BJ, Recht B, et al. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986;14: 305-11.
24. Bernstein JE, Parish LC, Rapaport M, et al. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 1986;15:504-7.
25. Gordon M, Johnson WC, Burgoon CF Jr. Histopathology and histochemistry of psoriasis. II. Dynamics of lesions during treatment. Arch Pathol 1967;84:443-50.
26. Glinski W, Glinska-Ferenz M, Pierozynska-Dubowska M. Neurogenic inflammation induced by capsaicin in patients with psoriasis. Acta Derm Venereol 1991;71:51-4.
27. Glinski W, Brodecka H, Glinska-Ferenz M, et al. Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol 1994;33:356-60.
28. Kürkçüoglu N, Alaybeyi F. Topical capsaicin for psoriasis [letter]. Br J Dermatol 1990;123:549-50.
29. Fusco BM, Marabini S, Maggi CA, et al. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain 1994;59:321-5.
30. Fusco BM, Fiore G, Gallo F, et al. "Capsaicin-sensitive" sensory neurons in cluster headache: pathophysiological aspects and therapeutic indication. Headache 1994;34:132-7.
31. Sicuteri F, Fanciullacci M, Nicolodi M, et al. Substance P theory: a unique focus on the painful and painless phenomena of cluster headache. Headache 1990;30:69-79.
32. Marks DR, Rapoport A, Padla D, et al. A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia 1993;13:114-6.
33. Stovner LJ, Sjaastad O. Treatment of cluster headache and its variants. Curr Opin Neurol 1995;8:243-7.
34. Watson CP, Evans RJ: The postmastectomy pain syndrome and topical capsaicin: a randomized trial. Pain 1992;51:375-9.
35. Dini D, Bertelli G, Gozza A, et al. Treatment of the post-mastectomy pain syndrome with topical capsaicin. Pain 1993;54:223-6.
36. Assa J. The intercostobrachial nerve in radical mastectomy. J Surg Oncol 1974;6:123-6.
37. Filiaci F, Zambetti G, Ciofalo A, et al. Local treatment of a specific nasal hyperreactivity with capsaicin. Allergol Immunopathol 1994;22:264-8.
38. Rinder J, Stjärne P, Lundberg JM. Capsaicin de-sensitization of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline. Rhinology 1994;32:173-8.
39. Anonymous. Capsaicin - a topical analgesic. Med Lett Drugs Ther 1992;34:62-3.
40. Jancsó N, Jancsó-Gábor A, Szolcsányi J: Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 1967;31:138-51.
41. Eberle L, Glück U. Klinische erfahrungen mit lokaler capsaicinbehandlung bei chronischer rhinopathie. HNO 1994;42:665-9.
42. Riechelmann H, Davris S, Bader D. Behandlung der perennialen nichtallergischen rhinopathie mit capsaicin. HNO 1993;41:475-9.
43. Lundblad L, Lundberg JM, Änggard A, et al. Capsaicin-sensitive nerves and the cutaneous allergy reaction in man: possible involvement of sensory neuropeptides in the flare reaction. Allergy 1987;42:20-5.
44. Berger A, Henderson M, Nadoolman W, et al. Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy. J Pain Symptom Manage 1995;10:243-8.
45. Woo S-B, Sonis ST, Monopoli MM, et al. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993;72:1612-7.
46. Jancsó G, Király E, Jancsó-Gábor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977;270:741-3.
47. Fowler CJ, Beck RO, Gerrard S, et al. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994;57:169-73.
48. Nitti VW. Intravesical capsaicin for treatment of neurogenic bladder. Lancet 1994;343:1448.
49. Anonymous. Loin pain/haematuria syndrome [editorial]. Lancet 1992;340:701-2.
50. Bultitude MI. Capsaicin in treatment of loin pain/haematuria syndrome [letter]. 1995;345:921-2
51. Mathias BJ, Dillingham TR, Zeigler DM, et al. Topical capsaicin for chronic neck pain: a pilot study. Am J Phys Med Rehab 1995;74: 39-44.
52. The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991;151:2225-9.
53. Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994;77:135-40.
54. Pfeifer MA, Ross DR, Schrage JP, et al. A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 1993;16:1103-15.
55. Tandan R, Lewis GA, Krusinski PB, et al. Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term followup. Diabetes Care 1992;15:8-14.
56. Chad DA, Aronin N, Lundstrom R, et al. Does capsaicin relieve the pain of diabetic neuropathy? Pain 1990;42:387-8.
57. Ross DR, Varipapa RJ. Treatment of painful diabetic neuropathy with topical capsaicin [letter]. N Engl J Med 1989;321:474-5.
58. Scheffler NM, Sheitel PL, Lipton MN. Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 1991;81:288-93.
59. Watson CPN, Evans RJ, Watt VR. Postherpetic neuralgia and topical capsaicin [abstract]. Can J Neurol Sci 1988;15:197.
60. Peikert A, Hentrich M, Ochs G. Topical 0.025% capsaicin in chronic post-herpetic neuralgia: efficacy, predictors of response and longterm course. J Neurol 1991;238:452-6.
61. Bernstein JE, Bickers DR, Dahl MV, et al. Treatment of chronic postherpetic neuralgia with topical capsaicin: A preliminary study. J Am Acad Dermatol 1987;17:93-6.
62. Fusco BM, Alessandri M. Analgesic effect of capsaicin in idiopathic trigeminal neuralgia. Anesth Analg 1992;74:375-7.
63. Hawk RJ, Millikan LE. Treatment of oral postherpetic neuralgia with topical capsaicin. J Am Acad Dermatol 1988;27:336.
64. Don PC. Topical capsaicin for treatment of neuralgia associated with herpes zoster infection [letter]. J Am Acad Dermatol 1988;18:1135.
65. Westerman RA, Roberts RGD, Kotzmann RR, et al. Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster. Clin Exp Neurol 1988;25:71-84.
66. Bernstein JE, Korman NJ, Bickers DR, et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989;21:265-70.
67. Bucci FA Jr, Gabriels CF, Krohel GB. Successful treatment of postherpetic neuralgia with capsaicin. Am J Ophthalmol 1988;106:758-9.
68. Watson CPN, Tyler KL, Bickers DR, et al. A randomized vehiclecontrolled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993;15:510-26.
69. Carmichael JK. Treatment of herpes zoster and postherpetic neuralgia. Am Fam Phys 1991;44:203-10.
70. Weintraub M, Golik A, Rubio A. Capsaicin for treatment of post-traumatic amputation stump pain [letter]. Lancet 1990;336:1003-4.
71. Rayner HC, Atkins RC, Westerman RA. Relief of local stump pain by capsaicin cream [letter]. Lancet 1989;2:1276-7.
72. Schwartzman RJ, McLellan TL. Reflex sympathetic dystrophy: a review. Arch Neurol 1987;44:555-61.
73. Cheshire WP, Snyder CR. Treatment of reflex sympathetic dystrophy with topical capsaicin: case report. Pain 1990;42:307-11.
74. Wist E, Risberg T. Topical capsaicin in treatment of hyperalgesia. allodynia and dysesthetic pain caused by malignant tumour infiltration of the skin [letter]. Acta Oncol 1993;32:343-7.
75. Bernstein JE. Capsaicin in the treatment of dermatologic disease. Cutis 1987;39:352-3.
76. 1995 Physicians' desk reference. Forty-ninth Edition. Montvale, NJ: Medical Economics, Co. Inc., 1995.
77. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin: a meta-analysis. Eur J Clin Pharmacol 1994;46:517-22.
78. Basha KM, Whitehouse FW. Capsaicin: a therapeutic option for painful diabetic neuropathy. Henry Ford Hosp Med J 1991;39:138-40.
79. Tandan R, Lewis GA, Badger GB, et al. Topical capsaicin in painful diabetic neuropathy: effect on sensory function. Diabetes Care 1992;15:15-8.
80. Drake HF, Harries AJ, Gamester RE, et al. Randomized doubleblind study of topical capsaicin for treatment of post-herpetic neuralgia [abstract]. Pain 1990;5(suppl):S58.
81. Schnitzer TJ, Morton C, Coker S, et al. Effectiveness of reduced applications of topical capsaicin (0.025%) in osteoarthritis [abstract]. Arthritis Rheum 1992;35:S132.
82. McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 1992;19:604-7.
83. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991;13:383-95.